Pakistan launches Phase III trials for Chinese company Cansinobio's COVID-19 vaccine

Pakistan has launched Phase III clinical trials for Chinese company Cansinobio's COVID-19 vaccine candidate, a government minister and an official at the pharmaceutical company said on Tuesday. "Just launched the Phase III trials for a COVID-19 vaccine in Pakistan," said the minister for planning, Asad Umar.

The trials have begun, said Dr Hasan, an official with the pharmaceutical company.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)